KIYATEC specializes in providing advanced, 3D cell-based assays and diagnostics with superior physiologic relevance for more accurate ex vivo prediction of patient response to drugs. KIYATEC’s Greenville, South Carolina offices and labs are co-located with the Institute for Translational Oncology Research (ITOR) Clinical Research Unit on the main campus of the Greenville Health System, the 13th largest public hospital system in the United States. We utilize primary sourced cells and tissues, immunoassays, imaging and other analytical capabilities to provide valuable data and insight to meet the needs of the pharmaceutical, biotechnology and healthcare industries. KIYATEC is also developing robust phenotypic cell-based cancer diagnostics using viable tumor biopsies to assess patient-specific response to available therapeutic agents. By leveraging KIYATEC’s specialized expertise and clinical connectivity, we add significant value to our clients’ preclinical, adaptive or co-clinical trials, and post-approval small molecule and biologic programs. Our technologies and methods provide more accurate simulation of phenomenon inherent within the living systems of the human body. Accurate modeling of these dynamic conditions creates opportunity for enhanced diagnostics and advanced medical treatments that will benefit society through the resulting improvements in healthcare and its associated costs.
Predictive assays for determining in vitro drug response using primary tissues sourced from patients, PDX tissues sourced from global suppliers and cell lines.
3D cell culture model development services including complex co-cultures for immunotherapy / immuno-oncology therapeutics.
KIYATEC Inc. has not received any reviews.
KIYATEC Inc. has not received any endorsements.